TotalMarketCap

Immix Biopharma

IMMXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$597.316 M

$7.21 -9.60%

Close of 6 Nov 2026

As of 6 Nov 2026, Immix Biopharma (IMMX) has a market capitalization of $597.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$29.4M

Loss-making

Shares outstanding

71,539,314

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #176Kura OncologyKURA$606.3M
  2. #177ArriVent BioPharmaAVBP$602.5M
  3. #178Immix BiopharmaIMMX$597.3M
  4. #179Olema PharmaceuticalsOLMA$593.7M
  5. #180ApnimedAPMD$589.1M

What if Immix Biopharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$340,601.55

Per share 47,273× higher

Bitcoin $1.53T

$18,429.36

Per share 2,558× higher

Apple $5.02T

$60,501.86

Per share 8,397× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Immix Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.